Диссертация (1140142), страница 22

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 22)

- P.454-455.320. Wrotniak M., Bieleck T., Gadzik T.S. Current opinion about using theplatelet rich gel in orthopedics and trauma surgery // Orthop. Traumatol. Rehabil. 2007. - Vol.9. - P.227-238.321. Wu J., Zhou M., Wan Y. et al. CD8+ T cells from vitiligo perilesionalmargins induce autologous melanocyte apoptosis // Mol. Med.

Rep. - 2013. Vol.7(1).- P.237-241.322. Xie H., Zhou F., Liu L. et al. Vitiligo: How do oxidative stressinduced autoantigens trigger autoimmunity? // J. Dermatol. Sci. ‒ 2016. ‒ Vol. 81,№ 1. ‒ P. 3-9.323. Xie X., Zhang C., Tuan R.S. Biology of platelet-rich plasma and itsclinical application in cartilage repair // Arthritis Res.

Ther. ‒ 2014. ‒ Vol. 16, №1. ‒ P. 204.324. Yang L., Wei Y., Sun Y. et al. Interferon-gamma InhibitsMelanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+Cytotoxic T Lymphocytes in Vitiligo // Acta Derm. Venereol. ‒ 2015. ‒ Vol. 95,№ 6. ‒ P. 664-670.325. Yang Y., Li S., Zhu G.

et al. A similar local immune and oxidativestress phenotype in vitiligo and halo nevus // J. Dermatol. Sci. ‒ 2017. ‒ Vol. 87,№ 1. ‒ P. 50-59.326. Yao L., Liu Y., Song Y. et al. Successful Treatment of Stable Vitiligo133by Low-Density Cultured Autologous Melanocyte Transplantation Combined WithNarrowband Ultraviolet B Therapy // Dermatol. Surg. ‒ Epub 2017 Apr 24.327. Yones S.S., Palmer R.A., Garibaldinos T.M., Hawk J.L. Randomizeddouble-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vsNarrowband-UV-B therapy // Arch. Dermatol. ‒ 2007. ‒ Vol.

143, № 5. ‒ P. 578584.328. Yu H.S., Chang K.L., Yu C.L. et al. Alterations in IL-6, IL-8, GMCSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells inpatients with active vitiligo // J. Invest. Dermatol. - 1997. - Vol.108 (4).- P.527529.329. Yu R., Broady R., Huang Y. et al. Transcriptome analysis revealsmarkers of aberrantly activated innate immunity in vitiligo lesional and nonlesional skin // PLoS One.

‒ 2012. ‒ Vol. 7, № 12. ‒ P. e51040.330. Yu W., Wang J., Yin J. Platelet-rich plasma: a promising product fortreatment of peripheral nerve regeneration after nerve injury // Int. J. Neurosci. ‒2011. ‒ Vol. 121, № 4. ‒ P. 176-180.331. Zhang M., Park G., Zhou B., Luo D. Applications and efficacy ofplatelet-rich plasma in dermatology: A clinical review // J Cosmet Dermatol. 2018.

- Vol.17(5). - P.660-665.332. Zhang Z., Xu S.X., Zhang F.Y. et al. The analysis of genetics andassociated autoimmune diseases in Chinese vitiligo patients // Arch. Dermatol.Res. ‒ 2009. ‒ Vol. 301, № 2. ‒ P. 167-173.333. Zhou L., Shi Y.L., Li K. et al. Increased circulating Th17 cells andelevated serum levels of TGF-beta and IL-21 are correlated with human nonsegmental vitiligo development // Pigment Cell Melanoma Res.

‒ 2015. ‒ Vol. 28,№ 3. ‒ P. 324-329..

Характеристики

Список файлов диссертации